The acute efficacy of aripiprazole across the symptom spectrum of schizophrenia: a pooled post hoc analysis from 5 short-term studies.
J Clin Psychiatry., Jan;70(1):25-35 (2009)
An fMRI study of visual attention and sensorimotor function before and after antipsychotic treatment in first-episode schizophrenia.
Psychiatry Res., Apr;172(1):16-23 (2009)
Iloperidone for schizophrenia.
Expert Opin Pharmacother., Aug;11(12):2087-93 (2010)
Aripiprazole for late-life schizophrenia.
Clin Interv Aging., 5:253-8 (2010)
Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study.
Brain Stimul., Oct;3(4):187-99 (2010)
Quetiapine monotherapy for bipolar depression.
Expert Opin Pharmacother., Jul;12(10):1643-51 (2011)
A pharmacotherapy algorithm for stabilization and maintenance of pediatric bipolar disorder.
J Am Acad Child Adolesc Psychiatry., Jul;43(7):859-67 (2004)
Quetiapine for the treatment of acute bipolar mania, mixed episodes and maintenance therapy.
Expert Opin Pharmacother., Aug;13(11):1645-52 (2012)
Neurocognitive effects of repetitive transcranial magnetic stimulation in severe major depression.
Clin Neurophysiol., Jun;114(6):1125-32 (2003)
Elimination of 7-aminoclonazepam in urine after a single dose of clonazepam.
Anal Bioanal Chem., Aug;376(8):1198-204 (2003)
Serotonin receptors in platelets of bipolar and schizoaffective patients: effect of lithium treatment.
Psychopharmacology (Berl.)., Nov;170(2):115-23 (2003)
Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania.
J Affect Disord., Oct;82 Suppl 1:S103-11 (2004)
Divalproex sodium for pediatric mixed mania: a 6-month prospective trial.
Bipolar Disord., Jun;7(3):266-73 (2005)
A one-year open-label trial of risperidone augmentation in lithium nonresponder youth with preschool-onset bipolar disorder.
J Child Adolesc Psychopharmacol., Jun;16(3):336-50 (2006)
Mood stabilizers in the prevention of recurrent affective disorders: a meta-analysis.
Acta Psychiatr Scand., Dec;100(6):406-17 (1999)
Vagus nerve stimulation for severe depression.
J Psychosoc Nurs Ment Health Serv., Jul;45(7):43-51 (2007)
Transcranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatment.
J Clin Psychiatry., Feb;69(2):222-32 (2008)
CSF neurotensin concentrations and antipsychotic treatment in schizophrenia and schizoaffective disorder.
Am J Psychiatry., Jul;154(7):1019-21 (1997)
Elevated [3H]inositol 1,4,5-trisphosphate binding sites and expressed inositol 1,4,5-trisphosphate receptor protein level in platelets of depressed patients.
Psychopharmacology (Berl.)., Jul;138(1):47-54 (1998)
Protein kinase C in platelets of depressed patients.
Biol. Psychiatry., Nov;44(9):909-11 (1998)